AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Spire Healthcare Group PLC

Declaration of Voting Results & Voting Rights Announcements Jun 12, 2015

5328_rns_2015-06-12_92696c44-acfb-42db-9fbb-a45f2e8ab5c6.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0731Q

Spire Healthcare Group PLC

12 June 2015

Spire Healthcare Group plc (the "Company")

12 June 2015

GENERAL TEXT AMENDMENT

The following amendment has been made to the 'Total Voting Rights and Share Capital' announcement released on 29 May 2015 at 17.00 under RNS No 68520.

Total voting rights are amended to 401,081,391 shares and EBT holding shown.

All other details remain unchanged.

The full amended text is shown below.

Total Voting Rights and Share Capital - Replacement

In accordance with Rule 5.6.1R of the FCA's Disclosure Rules and Transparency Rules, the Company confirms that its total issued share capital at 29 May 2015 comprises 401,081,391 ordinary shares of 1 penny each, each of which carries one voting right per share.  

1,692,242 of these Ordinary Shares are held by Wealth Nominees Limited as custodian for Equiniti Trust (Jersey) Limited, the independent trustee, which is the Trustee of Spire Healthcare's 2015 Employee Benefit Trust (the "EBT Trustee").

The EBT Trustee has waived its rights to receive dividends in respect of these 1,692,242 ordinary shares. The total of 1,692,242 ordinary shares will be treated as treasury shares in the group's consolidated balance sheet in accordance with IAS 32.

The total number of the Company's shares with voting rights is therefore 401,081,391.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Rules and Transparency Rules. 

In the event of query contact:

Anthony Dand

Interim Deputy Company Secretary

020 7427 9092

This information is provided by RNS

The company news service from the London Stock Exchange

END

TVRSFWFLEFISESM

Talk to a Data Expert

Have a question? We'll get back to you promptly.